Welcome to our dedicated page for Youngevity International news (Ticker: YGYIP), a resource for investors and traders seeking the latest updates and insights on Youngevity International stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Youngevity International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Youngevity International's position in the market.
Youngevity International, Inc. (OTCM: YGYI) has declared a regular monthly dividend of $0.203125 per share for its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTCM:YGYIP) for the months of October, November, and December 2021. The dividend will be payable on November 15, December 15, and January 17 to holders of record as of October 31, November 30, and December 31 respectively. This announcement highlights the company's ongoing commitment to returning value to shareholders.
